MAR 28, 2018 6:00 AM PDT

Cannabis Impact on Pain and Opiate Use - A Clinician's Perspective

Speaker
  • Palliative Patient Care Corp
    Biography
      Dr. Kent Crowley has over 30 years experience in the pharmaceutical industry and clinical medicine. He obtained his Doctor of Pharmacy from the University of California, San Francisco; completed an ASHP Accredited Residency with Kaiser Permanente. He is an Advanced Fellow and Diplomat of the American Academy of Anti-Aging Medicine.

      At Silver State Trading, a 40,000 sq.ft. Clean Green cultivation and production facility in Sparks, NV, Dr. Crowley serves as the Director of Research and Development, overseeing the production of Trokie® products and future patents. Dr. Crowley is the founder and creator of Trokie®, a patented buccal delivery system for cannabis (U.S. Patent No.: 9,675,656 B2) and runs the California operations for Trokie California Inc.

      Dr. Crowley serves as the Chief Medical Officer of the Palliative Care Corp, a clinic in Huntington Beach, CA that has treated over 3000 patients incorporating cannabis in disease state treatment and symptoms management, whether as a primary treatment or complementary to traditional and/or other modalities. He has recently published on this effort in Frontiers in Neuroscience, Aug 2018.

      Dr. Crowley is a member of the Society of Cannabis Clinicians and on the Research Subcommittee, a member of the International Cannabinoid Research Society and a member of the Integrative Think Tank for University of California Irvine, Center for the Study of Cannabis.

    Abstract

    Pain management is the most commonly reported reason for seeking medical cannabis, which is associated with lower opioid use, fewer medication side effects and better quality of life in patients with chronic pain. In a nation undergoing an opioid epidemic and beginning to understand more about the impacts of chronic pain, cannabis is becoming more and more of an appealing option for patients and doctors alike. Unfortunately, our government has ignored the evidence.

    This session will feature Dr. Crowley who recently led a study examining the efficacy of standardized, cannabis-based formulations to manage chronic non-cancer pain, exploring the findings, which indicate that cannabis is a safe and effective pain management tool. Dr. Crowley will also discuss opiate use and the reduction of opioid medication while using cannabis for pain management.

    Learning Objectives:

    • Review the current status of the opiate crisis in the United States
    • Explore the results of a recent study examining cannabis as a treatment for noncancer pain
    • Identify approaches to use and standardized formulas to deliver cannabis in a reliable way
    • Discuss the implications of adding cannabis to a pain management strategy

    Show Resources
    You May Also Like
    DEC 02, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    OCT 22, 2020 8:00 AM PDT
    C.E. CREDITS
    OCT 22, 2020 8:00 AM PDT
    Abstract: Detection and/or amplification of target DNA sequences by polymerase chain reaction (PCR) is a prevalent method in molecular biology. PCR has a broad range of applications, includi...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    Loading Comments...
    Show Resources
    Attendees
    • See more